Javara Research
Javara Research is an Integrated Research Organization that embeds Clinical Trial Navigators within healthcare partner facilities across eight US states, delivering community-based clinical trial execution to biopharmaceutical companies, CROs, and health systems serving over 5 million patients.
- Company typePrivate
- Founded2019
- HeadquartersWinston Salem, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Javara Research does
Javara Research is a privately held Integrated Research Organization (IRO) founded in 2019 and headquartered in Winston-Salem, North Carolina, that embeds clinical trial operations within healthcare partner facilities to deliver Clinical Research as a Care Option (CRAACO). The company's core model places dedicated Clinical Trial Navigators—specialized Javara staff—inside partner health systems, hospitals, and physician practices, where they run trials alongside routine care delivery rather than at standalone research sites. This architecture is supported by behind-the-firewall EHR integration for real-time protocol matching, centralized regulatory, contracts, training, and activation infrastructure, and a technology stack combining Florence eRegulatory, Clinical Conductor CTMS, Devana Solutions analytics, ClinCard stipend payments, and an LLM-based patient screening chatbot called Captain Chartwell. The company holds a 21 CFR Part 11 compliance posture and operates across eight US states (North Carolina, Georgia, Texas, Maryland, Minnesota, Nevada, Virginia) through seven named anchor partners including Atrium Health Wake Forest Baptist, Texas Health Resources, Privia Health, Cape Fear Valley Health, Mankato Clinic, Nevada Health Centers, and Tryon Medical Partners, reaching over 5 million patients and 5,800 practitioners.
Javara generates revenue through professional services and managed services contracts with biopharmaceutical companies, Contract Research Organizations (CROs), and healthcare organizations, billing for clinical trial setup, patient recruitment, site management, and data delivery across a single contract template and per-patient budget. Customer-reported outcomes include 96% investigator retention after the first trial (versus a 40% industry average), 90% patient re-participation intent, and 95% patient agreement that clinical research improved quality of care—metrics the company attributes to the embedded navigator model. The company is led by founder and CEO Jennifer Byrne (formerly of PMG Research) with co-founders Linda McCarty (Chief Legal Officer) and Amanda Wright (SVP Strategic Solutions), and is backed by General Atlantic following a $40 million strategic growth investment in April 2022. Total disclosed funding across rounds from 2019 through 2025 totals roughly $69.7 million, and the company expanded into oncology research with a top-five pharma award in February 2026.
Javara Research firmographics
Firmographics- Name
- Javara Research
- Legal name
- Javara Inc.
- Website
- https://javararesearch.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Javara Research is an Integrated Research Organization that embeds Clinical Trial Navigators within healthcare partner facilities across eight US states, delivering community-based clinical trial execution to biopharmaceutical companies, CROs, and health systems serving over 5 million patients.
- Ownership category
- akta.pro rank
Javara Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
- akta.pro secondary industries
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Healthcare Data Lakes, Lakehouses & Cloud Warehouses (HLACAIAA), Provider Credentialing, Licensing & Compliance Enablement (multi-state) (HLALAKAM)
Keywords
Where Javara Research is headquartered
LocationHeadquarters
- HQ city
- Winston Salem
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Javara Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Research Services for Biopharma/CROs: Javara provides clinical trial execution services to pharmaceutical companies and Contract Research Organizations. The company delivers high-quality data from diverse patient populations through its integrated network of healthcare partners, charging for clinical research services including study setup, patient recruitment, site management, and data delivery.
- Healthcare System Partnership Model: Javara partners with healthcare organizations to provide integrated clinical research infrastructure, assuming financial risk by providing comprehensive clinical research infrastructure including compliance. Healthcare partners gain access to clinical trials without direct investment in staff or infrastructure.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Variable participant compensation based on study requirements |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels10 records
Javara Research product offering
Product offeringCore offering
Javara operates as an Integrated Research Organization that delivers clinical trial execution services to biopharmaceutical companies and Contract Research Organizations by embedding research infrastructure and Clinical Trial Navigators at the point of care within partner healthcare systems. The company runs centralized regulatory, contracts, training, and activation operations; provides AI-powered patient screening (Captain Chartwell), EHR-based protocol matching, eConsent, telehealth, eSource, and eRegulatory technology; and delivers quality data from diverse patient populations across its healthcare partner network spanning eight US states.
Product overview
Javara Research is a leading Integrated Research Organization (IRO) that operates as a unified clinical research platform offering multiple interconnected services. The core offering is Clinical Research as a Care Option (CRAACO), which integrates clinical research at the point of care alongside trusted providers. Supporting services include Clinical Trial Navigators who guide patients through the research journey, technology-enabled features (eConsent, eSource, eRegulatory, Telehealth), and AI-powered screening via Captain Chartwell. The company serves biopharma companies, CROs, and healthcare organizations through a network of healthcare partners, enabling diverse patient access to clinical trials.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research as a Care Option (CRAACO) / Integrated Research Organization (IRO) Services Javara's flagship service model that embeds clinical research infrastructure, regulatory, contracts, training, and quality programs within partner healthcare systems so biopharma sponsors and CROs can run trials through existing community care delivery, with centralized study setup, patient recruitment, site management, and data delivery.
- Clinical Trial Navigator Program Dedicated Javara staff embedded at the point of care at every partner site who guide patients through a personalized research process, partner with investigators, and manage trial conduct to deliver reliable data and high investigator retention (96% after first trial versus a 40% industry average).
- Healthcare Partner Network (Clinical Trial Site Network) Managed-service partnership program in which Javara assumes financial and operational responsibility for delivering clinical research at partner healthcare organizations, providing staff, training, and infrastructure so partners offer trials without building their own research programs; network spans 8 states and reaches over 5 million patients and 5,800 practitioners across partners such as Atrium Health Wake Forest Baptist, Texas Health Resources, Privia Health, Cape Fear Valley Health, Mankato Clinic, Nevada Health Centers, and Tryon Medical Partners.
Quantifiable outcome
- 96% of Javara Investigators remained in research after their first trial (compared to 40% industry average)
- +3 more outcomes
Companies that use Javara Research
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
Javara Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability5 records
Feature10 records
Javara Research partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Texas Health ResourcescoreCollaboration to expand community-based clinical research across North Texas. Texas Health serves more patients than any other provider in North Texas across 29 hospitals, 420+ points of access, serving 16 counties and 8+ million people. Initial focus on cardiovascular disease, cardiometabolic disease, gastroenterology, and internal medicine.
- Cape Fear Valley HealthcoreStrategic partnership with North Carolina's 8th largest health system (8 hospitals, 1,000+ physicians) to offer clinical trial opportunities to diverse patient population in Fayetteville area. Specialty capabilities include Oncology, Cardiology, Neurology, Psychiatry, Pediatrics, Women's Health and Family Health.
- Nevada Health CenterscoreFirst-ever partnership between a clinical research organization and a Federally Qualified Health Center (FQHC). NVHC is largest primary care provider for uninsured, underinsured, and geographically isolated Nevadans with 18 locations and nearly 100 practitioners. Initial focus on Reno and Carson City.
- Mankato CliniccorePartnership with Minnesota's largest physician-owned, multispecialty regional group practice (190 physicians/practitioners across 11 locations in 4 communities). First clinical trials in pediatrics began Q3 2022.
- Atrium Health Wake Forest BaptistcoreIntegrated Research Agreement extending partnership to provide clinical research services at point of care within Wake Forest Baptist Health's community healthcare clinics and designated medical centers. Partnership covers 24 counties in northwest North Carolina and southwest Virginia.
- Privia HealthcorePartnership with national physician organization (2,500+ providers) to integrate clinical trials into Privia Medical Group care centers in Georgia, Gulf Coast, Mid-Atlantic, and North Texas, serving 2.8 million patients. Trials in endocrinology, internal medicine, women's health, and men's health.
- Tryon Medical PartnerscorePartnership with independent practice (100+ physicians, 8 clinics, 110,000 patients) to offer outpatient clinical trials in Charlotte region. Initial trials in internal medicine, endocrinology, and dermatology with goal of 35-45 trials within first 18 months.
- Uber HealthminorPartnership to provide prepaid patient transportation to study visits through Uber Health, making clinical research more convenient for participants.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Javara Research competitors and assessment
Company assessmentBroad incumbents
- WCG (WIRB-Copernicus Group): Clinical services company providing central IRB, eRegulatory (Florence — used by Javara), and trial quality/compliance services. Comparable as an enabling clinical research services player; board member Patricia Leuchten founded The Avoca Group, which was acquired by WCG.
- ICON plc: Top global CRO offering full-service clinical research and site-management capabilities to biopharma sponsors. A broader incumbent that could replicate embedded/point-of-care models, and competes for the same clinical delivery budget Javara targets.
- IQVIA: Largest global CRO and clinical research services provider, formed from the Quintiles/IMS merger. Javara board member Tom Pike was previously CEO of Quintiles. IQVIA competes for the same biopharma sponsor spend but at global scale across the full clinical development lifecycle.
- Fortrea (formerly Labcorp Drug Development): Global CRO spun off from Labcorp in 2023 and led by Tom Pike (a Javara board director) as Chairman/CEO until May 2025. Competes with Javara for biopharma clinical trial awards but operates a vastly broader full-service CRO model with global sites.
Direct peers
- Velocity Clinical Research: Privately held integrated site network operating multi-site clinical research across therapeutic areas. Highly comparable to Javara as both run owned/affiliated site networks delivering trials for biopharma sponsors, with Beau Garland (Javara's Chief of Site Operations) previously leading recruitment at Velocity.
- PMG Research: Integrated clinical research site network where Javara's founder Jennifer Byrne previously served as CEO. PMG operates community-based research sites serving biopharma sponsors with similar model and patient-access thesis as Javara.
- Circuit Clinical: Integrated research organization focused on embedding clinical trials into community physician practices, with a similar point-of-care delivery model and physician-network approach. Directly comparable to Javara's CRAACO framework.
- Flourish Research: Multi-site clinical research organization formed from the merger of several US site networks, offering integrated trial execution services to biopharma and CROs. Directly comparable to Javara in operating dedicated research sites and managing sponsor relationships across a growing US footprint.
Emerging players
- Medable: Decentralized clinical trial technology platform providing eCOA, eConsent, telehealth, and remote data capture capabilities. Adjacent/overlapping with Javara's tech stack (eConsent, eSource, telehealth) and the broader shift to decentralized trial operations.
- Science 37: Decentralized clinical trial technology and operations platform enabling patient participation in trials outside traditional site settings. Comparable to Javara in targeting decentralized/patient-centric trial delivery, though Science 37 is more tech-centric vs. Javara's embedded-staff model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Javara Research social profiles
Digital presenceJavara Research compliance and trust
Trust signalCompliance1 record
Javara Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Javara Research leadership team
Management profileNumber of profiles
Profiles15 records
Javara Research funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Javara Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Javara Research
What does Javara Research do?
Javara operates as an Integrated Research Organization that delivers clinical trial execution services to biopharmaceutical companies and Contract Research Organizations by embedding research infrastructure and Clinical Trial Navigators at the point of care within partner healthcare systems. The company runs centralized regulatory, contracts, training, and activation operations; provides AI-powered patient screening (Captain Chartwell), EHR-based protocol matching, eConsent, telehealth, eSource, and eRegulatory technology; and delivers quality data from diverse patient populations across its healthcare partner network spanning eight US states.
Is Javara Research a public or private company?
Javara Research is a private company. It is classified as venture growth investor backed and is currently operating.
When was Javara Research founded?
Javara Research was founded in 2019. It employs 101 to 250 people.
Where is Javara Research based?
Javara Research is headquartered in Winston Salem, United States, in the North America region.
How does Javara Research make money?
Two revenue lines are on record. Clinical Research Services for Biopharma/CROs are the primary driver. The others are healthcare System Partnership Model.
Who are Javara Research's main competitors?
Broad incumbents on record are WCG (WIRB-Copernicus Group), ICON plc, IQVIA and Fortrea (formerly Labcorp Drug Development). Direct peers are Velocity Clinical Research, PMG Research, Circuit Clinical and Flourish Research. Emerging players are Medable and Science 37.
Does Javara Research have an API?
No public API is recorded for Javara Research.
What industry is Javara Research in?
Javara Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 5417 and its SIC code is 8731.